Evaluation of the clinical outcome, prescription patterns and cost of treatment in patients with lupus nephritis in a tertiary care hospital.

Seth GS Medical College and KEM Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Male or female patients, whose age is 16 and above ,attending Rheumatology clinic (OPD and IPD).
•2. All classes of lupus nephritis diagnosed by ACR criteria, with proven renal biopsy ISN/RPS lupus nephritis.
•3. Assent from patient and written informed consent from parent or guardian whose age is 16- <18 years.
•4. Written informed consent for patients whose age is > 18 years.

•1. Pregnant and lactating women.
•2. Patients with lupus nephritis presenting with overlap syndrome and mixed connective tissue disorders. ( interfere with interpretation related to outcome of LN).
•3. Critically ill patients of SLE with lupus nephritis requiring emergency management / admitted in ICU.
•4. Co morbidities: Hypertension, diabetes, not controlled with medications. (interfere with clinical outcome assessment).
•5. Patients diagnosed as tuberculosis, or hepatitis B, or hepatitis C (break in Rx or any severe systemic illness which will interfere with interpretation related to outcome of LN in the opinion of investigators.
•6. Drug-induced lupus (Confounding factor).

发起方

Seth GS Medical College and KEM Hospital